Literature DB >> 20185782

Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: the MOBILIZE Boston study.

Ihab Hajjar1, Farzaneh Sorond, Yi-Hsiang Hsu, Andrew Galica, L Adrienne Cupples, Lewis A Lipsitz.   

Abstract

BACKGROUND AND
PURPOSE: Our objective was to investigate the associations between polymorphisms in representative genes of the renin angiotensin system with measures of cerebral blood flow regulation in older adults.
METHODS: Participants in this analysis were white subjects (n=335) in the MOBILIZE Boston study (Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston), an observational study of community-dwelling elders who underwent transcranial Doppler while sitting and standing and during hypercapnea and hypocapnea. Autoregulation phenotype was the change in cerebrovascular resistance from sit to stand. Vasoreactivity phenotype was the slope of the change in cerebrovascular conductance versus change in end-tidal CO2. A total of 33 tagged single nucleotide polymorphisms were selected in the angiotensinogen gene, the angiotensin converting enzyme gene, and the angiotensin receptor gene. Regression analyses adjusted for age, gender, body mass index, mean arterial blood pressure, stroke, and use of antihypertensives were conducted for each single nucleotide polymorphism and outcome. Bonferroni corrections were used to adjust P values for multiple testing.
RESULTS: In the angiotensinogen gene, only the rs699 single nucleotide polymorphism was associated with vasoreactivity after Bonferroni correction (P=0.00028). Homozygous carriers of the CC genotype of this single nucleotide polymorphism had lower vasoreactivity compared with the CT or TT genotypes. There were no significant associations with autoregulation measures. None of the single nucleotide polymorphisms in the other genes were associated with our phenotypes.
CONCLUSION: This analysis suggests that the angiotensinogen gene may be involved in vasoreactivity independent of blood pressure. Larger studies are needed to confirm the role of this gene in cerebrovascular health and aging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185782      PMCID: PMC3563282          DOI: 10.1161/STROKEAHA.109.572669

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  38 in total

1.  Heritability of blood pressure and hemodynamics in African- and European-American youth.

Authors:  Harold Snieder; Gregory A Harshfield; Frank A Treiber
Journal:  Hypertension       Date:  2003-04-28       Impact factor: 10.190

2.  Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.

Authors:  Y Nishimura; T Ito; J M Saavedra
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

3.  Baroreflex sensitivity and variants of the renin angiotensin system genes.

Authors:  A Ylitalo; K E Airaksinen; A Hautanen; M Kupari; M Carson; J Virolainen; M Savolainen; H Kauma; Y A Kesäniemi; P C White; H V Huikuri
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

4.  Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.

Authors:  Hanke Mollnau; Maria Wendt; Katalin Szöcs; Bernard Lassègue; Eberhard Schulz; Mathias Oelze; Huige Li; Martin Bodenschatz; Michael August; Andrei L Kleschyov; Nikolaus Tsilimingas; Ulrich Walter; Ulrich Förstermann; Thomas Meinertz; Kathy Griendling; Thomas Münzel
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

5.  Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.

Authors:  Haruki Yamakawa; Miroslava Jezova; Hiromichi Ando; Juan M Saavedra
Journal:  J Cereb Blood Flow Metab       Date:  2003-03       Impact factor: 6.200

6.  Role of nitric oxide in the regulation of cerebral blood flow in humans: chemoregulation versus mechanoregulation.

Authors:  Shahar Lavi; Rania Egbarya; Ronit Lavi; Giris Jacob
Journal:  Circulation       Date:  2003-03-10       Impact factor: 29.690

7.  Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project.

Authors:  Maurizio Castellano; Nicola Glorioso; Daniele Cusi; Riccardo Sarzani; Bruno Fabris; Giuseppe Opocher; Carmine Zoccali; Raffaello Golin; Franco Veglio; Massimo Volpe; Franco Mantero; Francesco Fallo; Gian Paolo Rossi; Cristina Barlassina; Laura Tizzoni; Fabiana Filigheddu; Mara Giacchè; Federica Rossi
Journal:  J Hypertens       Date:  2003-10       Impact factor: 4.844

8.  Cerebral autoregulation indices are unimpaired by hypertension in middle aged and older people.

Authors:  Penelope J Eames; Melanie J Blake; Ronney B Panerai; John F Potter
Journal:  Am J Hypertens       Date:  2003-09       Impact factor: 2.689

9.  Endothelin-I and angiotensin II inhibit arterial voltage-gated K+ channels through different protein kinase C isoenzymes.

Authors:  Richard D Rainbow; Robert I Norman; Diane E Everitt; Jennifer L Brignell; Noel W Davies; Nicholas B Standen
Journal:  Cardiovasc Res       Date:  2009-05-08       Impact factor: 10.787

10.  Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.

Authors:  Takeshi Ito; Haruki Yamakawa; Claudia Bregonzio; José A Terrón; Alicia Falcón-Neri; Juan M Saavedra
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

View more
  4 in total

Review 1.  Genetic Variation and Impact on Outcome in Traumatic Brain Injury: an Overview of Recent Discoveries.

Authors:  Alwyn Gomez; Carleen Batson; Logan Froese; Frederick A Zeiler
Journal:  Curr Neurol Neurosci Rep       Date:  2021-03-10       Impact factor: 5.081

2.  Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.

Authors:  Ihab Hajjar; Meaghan Hart; Yu-Ling Chen; Wendy Mack; Vera Novak; Helena C Chui; Lewis Lipsitz
Journal:  J Am Geriatr Soc       Date:  2013-01-25       Impact factor: 5.562

3.  Stroke, high blood pressure and the Renin-Angiotensin-aldosterone system - new developments.

Authors:  Jeffrey Atkinson
Journal:  Front Pharmacol       Date:  2011-04-27       Impact factor: 5.810

4.  Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.

Authors:  Hyun-Kyung Park; Myung-Chun Kim; Sung-Min Kim; Dae Jean Jo
Journal:  Exp Ther Med       Date:  2012-01-11       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.